Global Peptide-based Cancer Therapeutics Market Size, Share, and COVID-19 Impact Analysis, By Class (Peptide Hormone Analogues, Peptide-Drug Conjugates, and Vaccines/Others), By Indication (Prostate & Breast, Neuroendocrine/GI, and Melanoma/Others), By Line of Therapy (2L/3L, 1L, and Adjuvant/Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare

RELEASE DATE Oct 2025

REPORT ID SI16235

PAGES 275

REPORT FORMAT

Description Table of Contents Scope of Report Methodology

Full Name *

Business Email *

Phone Number (With Area Code) *

Company

15% Free customization, please feel free to let us know your detailed research requirements

Your personal details will remain secure and confidential - Privacy Policy

Share your Requirements

Need help to buy this report?